Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-PD-1 Therapy”

580 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 580 results

Testing effectiveness (Phase 2)UnknownNCT05512520
What this trial is testing

Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 126
Testing effectiveness (Phase 2)UnknownNCT05138146
What this trial is testing

Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT04139057
What this trial is testing

EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Xinqiao Hospital of Chongqing 10
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Testing effectiveness (Phase 2)Study completedNCT03278665
What this trial is testing

4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy

Who this might be right for
Malignant Melanoma
4SC AG 40
Testing effectiveness (Phase 2)WithdrawnNCT04001101
What this trial is testing

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Who this might be right for
Microsatellite Instability HighMismatch Repair DeficiencyColorectal Cancer
University of Colorado, Denver
Not applicableUnknownNCT06281912
What this trial is testing

Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients

Who this might be right for
Early MelanomaAdvanced Melanoma
Azienda Ospedaliera di Perugia 70
Early research (Phase 1)UnknownNCT05225116
What this trial is testing

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Early research (Phase 1)Ended earlyNCT05859464
What this trial is testing

ZL-1218 in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumor
Zai Lab (Hong Kong), Ltd. 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03480334
What this trial is testing

Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 26
Large-scale testing (Phase 3)Active Not RecruitingNCT04586231
What this trial is testing

Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 747
Not applicableUnknownNCT04889768
What this trial is testing

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery
Zhejiang Cancer Hospital 46
Testing effectiveness (Phase 2)Study completedNCT04868708
What this trial is testing

AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Akeso 50
Testing effectiveness (Phase 2)UnknownNCT04098796
What this trial is testing

PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaAFP
China Medical University, China 30
Testing effectiveness (Phase 2)UnknownNCT05461235
What this trial is testing

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

Who this might be right for
PD-1 AntibodyDC-CellNK-Cell+1 more
China Medical University, China 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04462406
What this trial is testing

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Who this might be right for
Advanced MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+8 more
ECOG-ACRIN Cancer Research Group 150
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284787
What this trial is testing

BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02840994
What this trial is testing

A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bavarian Nordic 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Load More Results
60